Triptorelin
Published · Researched 2026-09-21
Category: Libido, Tanning, Sleep & Niche · Research date: 2026-09-20 · Slug: triptorelin
Overview
Triptorelin is a synthetic GnRH agonist — the [D-Trp6]-modified analogue of native GnRH, designed for high receptor affinity and a long duration of action. Its pharmacology is the mirror image of gonadorelin's: sustained exposure desensitizes pituitary GnRH receptors, shutting down LH/FSH and downstream sex steroids. That is the basis of its legitimate medical uses (prostate cancer, endometriosis, precocious puberty — as Trelstar, Decapeptyl, Triptodur depot injections). In grey-market bodybuilding/TRT lore it has a notorious nickname — the "two-shot PCT" — from anecdotes claiming a single dose permanently restarted natural testosterone production after steroid cycles. It sells as 2 mg lyophilized vials from research vendors. The anecdote base is dramatic, thin, and medically implausible as a general claim.
Social standing
Cross-platform: Honestly weak. Retrieval was dominated by unrelated peptide content; no verified Facebook-group item discussion, no Threads owner thread, and no Instagram owner-testimonial corpus specific to triptorelin were found in this pass. What exists:
- Vendor product pages (Umbrella Labs, SwissChems, CertaPeptides) with bodybuilding-adjacent copy.
- A South African vendor page (buypeptides.co.za) repeating the "TWO-SHOT PCT" anecdote verbatim — illustrating how the lore propagates through vendor copy rather than owner reports.
- The broader ExcelMale/TRT-forum world discusses HPTA restart strategies, but triptorelin-specific owner threads with verifiable detail were not isolated in this pass.
Recurring praise (lore-level): the "single shot restarted everything" anecdote; positioned as the nuclear option for post-cycle recovery.
Recurring complaints: the same mechanism that "restarts" can also produce chemical castration if misused — a risk the lore underplays; no community dosing consensus exists; vendor copy is the primary information source, which is a red flag.
Social validation
Tier: Tier 3 — no verified organic owner discussion on any surveyed platform; the item's reputation rests on recycled anecdote and vendor copy.
Named sources and what each proves:
- Vendor listings (CertaPeptides €29.99, Umbrella Labs $40.99, SwissChems $29.95, Ultima $43) — prove the 2 mg vial is actively sold; nothing more.
- buypeptides.co.za product copy — proves the "TWO-SHOT PCT" anecdote is vendor-propagated lore, not fresh owner evidence.
- Absence of social results — itself a finding: an item with this dramatic a reputation generates no visible owner discussion.
Key specs table
| Spec | Detail |
|---|---|
| Identity | Triptorelin, [D-Trp6]-GnRH synthetic decapeptide GnRH agonist |
| Aliases | Decapeptyl, Trelstar, Triptodur, (D-Trp6)-GnRH, Arvekap (as catalog-listed) |
| Formula / MW | C64H82N18O13 · 1311.45 g/mol · CAS 57773-63-4 (as catalog-listed; primary-source verification not performed) |
| Target | GnRH receptor — sustained agonism → receptor desensitization → LH/FSH and sex-steroid suppression |
| Vial sizes (grey market) | 2 mg lyophilized per vial (standard) |
| Half-life | Long-acting by design (depot pharma products act over weeks–months); single-bolus kinetics in self-use — UNVERIFIED in this pass |
| Community-reported research use | "HPTA restart"/"two-shot PCT" lore; no verified community dosing consensus observed. Reported behavior only — not instructions. |
| Storage | Lyophilized: refrigerated per vendors ("store cold, keep refrigerated; do NOT freeze" per one listing); −20 °C commonly stated for long-term |
Pricing
All prices observed 2026-09-20 from research-peptide vendor listings (grey market, research-use-only), 2 mg vials unless noted.
| Vendor | Price (2 mg vial) | Notes |
|---|---|---|
| CertaPeptides | €29.99 | cheapest observed; EU; volume tiers |
| SwissChems | $29.95 | 360 in stock per listing |
| Umbrella Labs | $40.99 | |
| Ultima (via reseller) | $43.00 | |
| buypeptides.co.za | R320 | South Africa |
| China wholesale (Hongbaiyi) | $40–45 per 10-vial box (2 mg/vial) | low-confidence supplier data, not street pricing |
| China EXW price list | $30 per 10-vial box (2 mg/vial) | wholesale supplier data, not street pricing |
- Street range: roughly $30–$43 per 2 mg vial (US), ~€30 (EU).
- Facebook Marketplace: not searched in this pass — used-value range UNVERIFIED.
- Pharmaceutical depot products (Trelstar/Decapeptyl/Triptodur): prescription channel, not surveyed.
What's included / what's needed
Vial listings ship the lyophilized 2 mg vial only (some vendors add a per-lot COA). Needed separately: bacteriostatic water, syringes. The pharmaceutical products are finished depot suspensions administered by clinicians — an entirely different product and channel.
Support reality
No manufacturer warranty on research vials; vendor guarantees are vendor policies only. The information environment is the worst in this track: vendor copy is the primary "educational" source, and it repeats the same unverified anecdote. No independent certification body exists.
Community verdict
Triptorelin has the most dramatic reputation and the least evidence in this track. The "two-shot PCT" story is compelling precisely because it's simple — one shot, full restart — but it survives as vendor copy, not as a living body of owner reports. The pharmacological reality (sustained GnRH agonism suppresses the axis; that suppression is the actual medicine) makes casual self-experimentation uniquely risky among the niche peptides. High lore, low signal, real downside.
Regulatory & safety status
- Approved pharmaceutical products exist — triptorelin as Trelstar (prostate cancer), Decapeptyl/Gonapeptyl (various), Triptodur (central precocious puberty) — for specified medical indications only, as depot formulations administered by clinicians.
- "HPTA restart" / "two-shot PCT" and grey-market research vials are unapproved — no regulatory standing whatsoever.
- The mechanism itself is the warning: sustained GnRH-receptor activation suppresses testosterone to castrate levels (this is the prostate-cancer therapy). Misuse can produce prolonged hypogonadism — the opposite of the lore's promise.
- Community adverse-event consensus: UNVERIFIED — no reliable reporting base was observed.
Image views
4 of 8 views obtained (vendor product images, JPEG; converted from WebP/PNG originals). Top-angle, scale, box-accessories, and real-owner-in-use views were unavailable.
- hero:
img/triptorelin-hero.jpg(Peptide Works Triptorelin 2 mg vial) - side:
img/triptorelin-side.jpg(Lavish Peptides Triptorelin Acetate 2 mg) - rear:
img/triptorelin-rear.jpg(Peptides Lab UK Triptorelin Acetate) - detail:
img/triptorelin-detail.jpg(Peptide Concierge triptorelin) - top-angle: unavailable
- scale: unavailable — no vendor image with a size reference found
- box-accessories: unavailable
- real-owner-in-use: unavailable — no verifiable real-owner product photos found
Not medical advice. This is research documentation only. Triptorelin research vials are not approved for human use; its "restart" lore describes unapproved self-experimentation with a drug class used medically to suppress sex hormones. Consult a licensed healthcare provider.
Named sources
- Vendor listings (CertaPeptides €29.99, Umbrella Labs $40.99, SwissChems $29.95, Ultima $43) — prove the 2 mg vial is actively sold
- buypeptides.co.za product copy — proves the "TWO-SHOT PCT" anecdote is vendor-propagated lore, not fresh owner evidence.
- Absence of social results — itself a finding: an item with this dramatic a reputation generates no visible owner discussion.
Source URLs were not recorded for these references.